No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
294 |
4. Check minimum number of eventsNone |
294 |
5. Include endpointsNone |
294 |
6. Filter based on genotype QC (FinnGen only) |
294 |
Control definitions (FinnGen only)
- Control exclude
- AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Unspecified parasitic disease
based on the number of shared cases.
Similar with more cases:
- Pediculosis, acariasis and other infestations
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3445 | 1243 | 2130 |
| Only index persons | 2322 | 862 | 1460 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.06 |
| Only index persons | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 32.23 | 33.08 | 31.02 |
| Only index persons | 26.02 | 24.89 | 26.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 294 | 131 | 163 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 27.38 | 21.15 | 32.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 269
- Matched controls
- 2688
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
13609
ICD-8 Finland
Other and unspecified infective and parasitic diseases, Morbus infectiosus sive parasitarius NUD
+∞
104.1
93
*
13603
ICD-8 Finland
Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis
+∞
88.5
80
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
49.5
46
*
13608
ICD-8 Finland
Other and unspecified infective and parasitic diseases
+∞
30.8
29
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.7
16.6
61
158
M02.3
ICD-10 Finland
Reiter disease
49.0
12.0
14
*
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
+∞
9.4
9
*
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
27.4
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
181
1371
1.83
5.85
11.9
9.6
4.2
4.2
e9/l
0.02
160
1211
33
138
2.57
5.45
1.9
1.6
—
—
—
0
0
152
1127
1.72
4.98
8.7
6.8
1.2
1.2
mmol/l
0.05
133
959
65
391
1.85
4.29
2.8
2.7
3.7
1.6
e6/l
0.53
40
218
26
112
2.45
4.05
1.7
1.8
1.5
1.6
g/l
0.28
21
97
67
416
1.79
3.98
2.7
2.5
2.1
1.1
e6/l
0.25
43
240
124
910
1.63
3.96
3.0
2.2
78.0
76.2
nmol/l
0.25
116
816
138
1040
1.62
3.95
6.9
5.9
1.2
1.2
mmol/l
0.20
130
956
96
667
1.65
3.78
3.8
2.9
0.5
0.5
e6/l
0.08
77
499
18
67
2.80
3.73
1.6
1.2
—
—
—
0
0
116
858
1.58
3.49
3.8
3.0
—
—
—
0
0
107
782
1.58
3.36
4.5
3.1
33.6
32.5
u/l
0.09
102
749
91
641
1.61
3.33
3.2
2.9
362.5
7922.9
umol/l
3.06
84
553
23
104
2.31
3.25
8.2
3.8
23.9
23.8
mmol/l
0.07
23
96
59
374
1.72
3.23
2.2
1.8
—
—
—
0
0
80
557
1.60
3.05
3.1
2.3
—
—
—
0
0
67
452
1.62
2.89
4.0
3.4
407.9
140.0
ng/l
0.52
55
341
173
1437
1.50
2.86
3.0
3.0
—
—
—
0
0
31
168
1.94
2.80
6.4
4.1
134.7
82.1
ng/l
1.25
26
151
45
278
1.73
2.70
5.4
4.4
207.8
243.6
u/l
2.93
45
265
9
24
3.83
2.69
1.1
1.1
—
—
—
0
0
164
1358
1.47
2.68
6.6
4.8
6.9
6.7
mmol/l
0.42
157
1269
120
937
1.47
2.64
2.3
2.0
89.9
94.6
pmol/l
0.50
58
509
61
416
1.59
2.51
1.8
1.7
1141.2
1172.6
nmol/l
0.08
49
325
35
206
1.79
2.47
6.4
6.7
1.1
1.3
mmol/l
0.80
35
195
71
504
1.54
2.45
2.1
1.7
1.2
1.2
mg/l
0.01
56
392
5
8
6.33
2.38
1.2
1.1
—
—
—
0
0
16
72
2.29
2.32
4.5
2.8
1.7
1.5
mg/l
0.36
16
66
11
43
2.62
2.12
3.5
3.2
3.2
4.6
e9/l
1.56
11
43
10
38
2.69
2.03
1.3
1.9
—
—
—
0
0
9
32
2.87
2.02
1.6
1.4
—
—
—
0
0
11
45
2.50
1.95
3.5
3.6
50.2
59.2
%
1.15
11
45
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
10
39
2.62
1.94
1.6
3.1
—
1265.4
u/ml
—
0
5
74
557
1.44
1.89
2.1
1.6
19.4
20.9
nmol/l
0.35
64
468
9
34
2.70
1.88
1.7
1.4
—
—
—
0
0
120
985
1.37
1.85
4.5
2.7
212.4
150.4
ug/l
0.78
113
921
205
1833
1.39
1.83
11.3
7.8
75.9
77.3
u/l
0.20
195
1728
5
12
4.22
1.83
1.0
1.2
—
—
—
0
0
40
267
1.58
1.81
2.4
1.7
—
—
—
0
0
10
41
2.49
1.77
1.1
1.0
—
—
—
0
0
8
30
2.71
1.73
4.3
3.4
—
—
—
0
0
5
13
3.89
1.72
1.4
1.1
—
—
—
0
0
135
1139
1.34
1.71
5.6
4.8
0.0
0.0
estimate
0.00
31
231
28
174
1.67
1.68
8.9
2.9
4.9
4.5
kpa
0.38
28
167
13
62
2.15
1.68
1.7
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
63
2.11
1.62
2.5
2.3
0.3
0.3
u/ml
—
7
37
39
267
1.53
1.59
2.5
1.8
—
—
—
0
0
35
235
1.56
1.56
3.0
2.1
341.3
372.9
nmol/l
0.46
35
216
8
33
2.46
1.55
1.5
1.4
—
—
—
0
0
134
1142
1.32
1.54
3.8
3.5
0.0
0.0
estimate
0.00
30
229
35
237
1.54
1.51
2.7
3.6
—
—
—
0
0
252
2363
1.47
1.49
21.6
14.3
23.6
23.5
mg/l
0.00
210
1872
31
205
1.57
1.48
13.9
7.7
10.7
10.2
mmol/l
0.18
31
198
32
215
1.55
1.43
11.1
3.7
5.9
5.6
kpa
0.93
32
209
257
2427
1.47
1.38
22.3
15.9
139.3
139.7
mmol/l
1.34
246
2367
5
17
2.97
1.36
1.8
1.6
12.8
14.0
u/l
—
5
17
134
1159
1.29
1.33
4.0
3.5
0.0
0.0
estimate
0.00
28
222
241
2255
1.38
1.32
4.2
4.0
1.4
1.3
mmol/l
1.15
226
2075
118
1005
1.29
1.32
6.9
4.7
35.1
35.6
g/l
0.43
106
951
193
1751
1.30
1.31
3.9
3.8
14.8
14.8
pmol/l
0.15
177
1578
40
291
1.43
1.24
31.0
22.9
1.4
1.4
inr
—
7
38
36
258
1.45
1.21
5.7
7.2
0.1
1.1
mmol/l
0.98
31
211
12
64
1.91
1.20
2.1
1.5
—
—
—
0
0
256
2431
1.41
1.17
22.7
16.1
4.0
4.0
mmol/l
0.61
245
2371
38
277
1.43
1.17
5.4
3.2
6.4
7.6
umol/l
0.36
32
241
235
2203
1.33
1.17
6.3
5.8
39.9
40.1
mmol/mol
0.09
217
2066
247
2333
1.37
1.16
4.8
4.5
1.4
1.4
mmol/l
0.84
231
2157
16
95
1.72
1.16
1.9
2.5
—
—
—
0
0
22
143
1.58
1.15
1.3
1.4
—
—
—
0
0
10
51
1.99
1.12
1.2
1.3
—
—
—
0
0
10
51
1.99
1.12
1.2
1.3
—
—
—
0
0
240
2262
1.33
1.11
19.1
13.1
78.6
81.1
ml/min/173m2
0.89
200
1883
11
59
1.90
1.09
1.2
1.2
—
—
—
0
0
83
693
1.28
1.06
3.3
3.1
1283.4
1223.3
ng/l
0.07
73
591
35
257
1.41
1.05
5.9
7.1
5.2
5.1
kpa
0.19
35
247
9
46
1.99
1.04
1.4
1.1
93.3
38.6
u/l
—
9
40
9
46
1.99
1.04
1.6
1.5
—
—
—
0
0
11
60
1.87
1.04
1.6
1.9
—
—
—
0
0
5
22
2.29
1.04
1.0
1.2
—
—
—
0
0
9
47
1.94
1.03
1.2
1.3
1.6
24.6
e6/l
—
9
34
9
47
1.94
1.03
1.6
1.4
164.0
251.1
e6/l
—
9
36
140
1247
1.23
1.01
8.9
6.7
9.7
11.6
umol/l
3.69
133
1187
228
2144
1.28
1.00
5.1
4.5
1.8
1.9
mu/l
1.03
216
1951
11
61
1.83
1.00
3.2
1.5
—
—
—
0
0
79
661
1.27
0.99
1.8
1.7
1.6
1.4
mmol/l
0.77
67
556
23
158
1.49
0.97
2.0
1.4
—
—
—
0
0
124
1095
1.23
0.96
6.3
3.9
—
—
—
0
0
6
27
2.25
0.94
1.0
1.6
—
—
—
0
0
27
195
1.42
0.90
3.0
2.8
51.9
67.1
ml/min/173m2
—
9
83
13
79
1.68
0.89
1.8
1.7
—
—
—
0
0
10
56
1.81
0.89
1.3
1.3
—
—
—
0
0
34
257
1.37
0.88
6.0
7.1
11.5
12.2
kpa
0.63
34
249
246
2348
1.29
0.86
4.8
4.5
4.5
4.6
mmol/l
0.73
232
2192
262
2522
1.36
0.86
14.8
10.6
35.7
26.8
u/l
0.49
256
2446
242
2306
1.28
0.85
4.7
4.6
6.2
6.0
mmol/l
0.82
218
2123
250
2392
1.30
0.85
5.4
5.0
2.7
2.7
mmol/l
0.35
236
2216
11
66
1.69
0.80
1.2
1.3
—
—
—
0
0
5
24
2.10
0.75
1.6
1.1
—
—
—
0
0
21
286
0.71
0.74
7.9
7.1
—
—
—
0
0
51
420
1.26
0.74
4.0
2.9
2.4
2.4
mmol/l
0.42
45
375
5
27
1.87
0.68
1.2
1.6
24.2
16.0
ug/l
—
5
27
5
27
1.87
0.68
1.4
1.2
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
269
2614
1.34
0.68
29.8
21.0
133.4
136.4
g/l
2.32
264
2579
25
325
0.75
0.67
1.5
1.4
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
11
70
1.59
0.66
2.7
2.2
517.8
111.8
ug/min
—
6
39
86
758
1.19
0.65
3.8
3.3
2.3
2.3
mmol/l
0.47
74
678
24
182
1.35
0.63
1.9
1.6
—
—
—
0
0
13
88
1.50
0.61
1.9
1.9
—
—
—
0
0
224
2142
1.19
0.61
23.4
15.0
39.9
40.1
%
0.18
172
1575
190
1793
1.17
0.61
6.2
4.0
15.1
11.9
mm/h
1.63
184
1661
11
72
1.55
0.60
1.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
3.4
—
65.5
—
0
22
11
73
1.53
0.57
1.0
1.2
—
—
—
0
0
60
520
1.19
0.55
1.5
1.2
2.0
1.9
u/ml
0.02
14
162
26
205
1.29
0.54
2.0
1.7
—
—
—
0
0
10
66
1.53
0.53
1.7
1.8
—
—
—
0
0
46
392
1.21
0.51
1.3
1.3
7.3
14.3
u/ml
0.48
14
155
55
478
1.19
0.50
1.7
1.7
380.8
434.8
pmol/l
1.07
49
395
7
106
0.65
0.49
2.3
2.2
147.3
35.4
u/ml
—
7
101
16
119
1.36
0.49
5.1
2.6
0.9
1.2
%
0.70
16
119
20
156
1.30
0.46
1.4
1.2
92.7
157.1
iu/ml
—
6
71
47
406
1.19
0.46
1.3
1.3
26.2
33.1
iu/ml
0.29
18
141
5
31
1.62
0.43
6.0
3.0
2.8
4.5
nmol/l
—
5
31
99
912
1.13
0.42
4.5
3.7
73.3
45.1
ng/l
0.51
69
645
5
33
1.52
0.41
1.6
3.1
—
29.7
—
0
10
11
83
1.34
0.32
1.6
2.7
—
—
—
0
0
13
102
1.29
0.30
1.2
1.7
—
—
—
0
0
8
63
1.28
0.28
1.6
1.3
—
—
—
0
0
8
63
1.28
0.28
1.5
1.2
—
—
—
0
0
20
234
0.84
0.26
1.3
1.8
—
—
—
0
0
12
96
1.26
0.25
1.8
1.3
29.4
30.8
iu/l
0.04
12
82
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
64
599
1.09
0.20
2.6
3.1
0.6
0.8
ug/l
1.83
50
404
6
48
1.26
0.20
1.2
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.2
—
0
9
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
12
99
1.22
0.20
2.0
2.0
26.7
5.6
ug/l
0.35
12
90
105
1005
1.07
0.19
4.0
5.0
1.9
2.8
ug/l
1.45
92
905
7
60
1.17
0.18
1.4
1.5
—
—
—
0
0
8
68
1.18
0.16
1.6
1.6
—
—
—
0
0
165
1611
1.06
0.15
4.2
3.1
55.4
49.2
u/l
0.46
151
1524
13
114
1.15
0.12
1.0
1.3
—
—
—
0
0
17
153
1.12
0.11
3.9
3.8
2.6
1.6
mmol/l
0.64
12
119
83
806
1.04
0.09
3.6
4.4
22.9
21.7
%
0.23
39
399
65
629
1.04
0.08
4.4
3.7
0.0
0.0
estimate
0.50
29
220
7
67
1.05
0.08
1.7
1.6
—
—
—
0
0
9
86
1.05
0.07
1.9
2.9
—
—
—
0
0
31
296
1.05
0.06
4.8
4.8
30.8
31.5
%
0.13
25
202
77
757
1.02
0.03
3.4
2.4
60.1
57.0
u/l
0.33
68
710
90
911
0.98
0.02
4.6
3.6
—
—
—
0
0
14
138
1.02
0.00
4.0
3.2
4.3
4.6
pmol/l
0.45
14
126
12
117
1.03
0.00
1.1
1.0
—
—
—
0
0
39
387
1.01
0.00
1.5
1.5
—
—
—
0
0
6
59
1.02
0.00
1.0
1.4
—
—
—
0
0
5
50
1.00
0.00
2.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
8
82
0.97
0.00
1.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
20.9
—
0
6
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_PARASITIC_NOS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_PARASITIC_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_PARASITIC_NOS – Unspecified parasitic disease
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data